omega-n-methylarginine has been researched along with Kidney Diseases in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Addabbo, F; Bachmann, S; Goligorsky, MS; Paliege, A; Patschan, D; Ratliff, B; Stoessel, A; Theilig, F; Waschke, J | 1 |
Blackwelder, WC; Hazen, SL; Kato, GJ; Machado, RF; Taylor, JG; Wang, Z | 1 |
Baylis, C; Erdely, A; Freshour, G | 1 |
Blantz, RC | 1 |
Chou, SY; Gulmi, FA; Kim, H; Lanzone, JA; Mooppan, UM | 1 |
Ruetten, H; Thiemermann, C; Vane, JR; Wu, CC | 1 |
Connor, J; Farrelly, LW; Gilkeson, GS; Hutchison, F; Manning, P; Redmond, ST; Reilly, CM; Ruiz, P; Viti, D | 1 |
Anderson, S; Brenner, BM; Gunning, M; King, AJ; Neuringer, JR; Troy, JL | 1 |
1 review(s) available for omega-n-methylarginine and Kidney Diseases
Article | Year |
---|---|
Vascular biology: relevance of nitric oxide in vascular and nonvascular tissue with normal and decreased renal function.
Topics: Amino Acid Oxidoreductases; Arginine; Endothelium, Vascular; Enzyme Induction; Hemodynamics; Humans; Hypotension; Inflammation; Kidney Diseases; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Shock, Septic | 1994 |
7 other study(ies) available for omega-n-methylarginine and Kidney Diseases
Article | Year |
---|---|
Indolent course of tubulointerstitial disease in a mouse model of subpressor, low-dose nitric oxide synthase inhibition.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Kidney; Kidney Diseases; Leukocytes; Mice; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Platelet Aggregation | 2008 |
Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death.
Topics: Anemia, Sickle Cell; Arginine; Case-Control Studies; Citrulline; Follow-Up Studies; Hemolysis; Humans; Hypertension, Pulmonary; Kidney Diseases; Linear Models; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen; Proportional Hazards Models; Risk; Survival Rate | 2009 |
Resistance to renal damage by chronic nitric oxide synthase inhibition in the Wistar-Furth rat.
Topics: Animals; Chronic Disease; Dose-Response Relationship, Drug; Kidney; Kidney Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitrogen Dioxide; omega-N-Methylarginine; Puromycin; Rats; Rats, Inbred WF; Rats, Sprague-Dawley; Time Factors | 2006 |
Renal hemodynamics in acute unilateral ureteral obstruction: contribution of endothelium-derived relaxing factor.
Topics: Acute Disease; Animals; Arginine; Dogs; Female; Hemodynamics; Hyperemia; Kidney; Kidney Diseases; Nitric Oxide; omega-N-Methylarginine; Regional Blood Flow; Ureteral Obstruction | 1995 |
The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase.
Topics: Animals; Arginine; beta-Aminoethyl Isothiourea; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Enzyme Induction; Enzyme Inhibitors; Kidney Diseases; Lipopolysaccharides; Male; Multiple Organ Failure; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Wistar | 1995 |
Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase.
Topics: Animals; Enzyme Inhibitors; Kidney; Kidney Diseases; Lysine; Mice; Mice, Inbred MRL lpr; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Proteinuria | 2002 |
Nitric oxide: a potential mediator of amino acid-induced renal hyperemia and hyperfiltration.
Topics: Amino Acids; Animals; Arginine; Glomerular Filtration Rate; Glycine; Hemodynamics; Hyperemia; Infusions, Intravenous; Kidney; Kidney Diseases; Male; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Renal Circulation | 1991 |